Printer Friendly

ADVANCED POLYMER SYSTEMS COMPLETES PIVOTAL PHASE III STUDIES

 REDWOOD CITY, Calif., Sept. 1 /PRNewswire/ -- Advanced Polymer Systems, Inc. (NASDAQ: APOS) has completed the two pivotal clinical efficacy studies on its Tretinoin Microsponge(R) Gel technology. These studies were carried out as part of the ongoing series of studies of the Phase III Investigational New Drug (IND) program on this project. APS and its outside consultants have reviewed the results of these studies and, based on these results, are continuing with the preparation for the filing of the NDA for review by FDA. Additional investigational work continues leading toward the filing.
 Advanced Polymer Systems develops, manufactures and sells patented Microsponge delivery systems which allow for the controlled release of active ingredients in a programmed manner in the ethical dermatology, cosmetic and personal care areas. Certain of these projects are conducted under the development and licensing arrangements with large companies, others as part of joint ventures in which APS is a major participant, and a number of projects are exclusive to APS.
 -0- 9/1/93
 /CONTACT: Michael O'Connell, chief financial officer of Advanced Polymer Systems, Inc., 415-366-2626; or Heidi A. Flannery, investor relations counsel of in.ves'com, 503-221-2087/
 (APOS)


CO: Advanced Polymer Systems, Inc. ST: California IN: HEA SU:

SM-WB -- NY028 -- 7884 09/01/93 10:48 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 1, 1993
Words:209
Previous Article:ACME METALS INC., UNITED STEELWORKERS AGREE TO NEW SIX-YEAR CONTRACT FOR ACME STEEL, ACME PACKAGING OPERATIONS
Next Article:NICHOLS-HOMESHIELD ANNOUNCES PLANS TO RESUME PRODUCTION AND SOLICIT ORDERS AT ITS LINCOLNSHIRE PLANT
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters